Your browser doesn't support javascript.
loading
Co-occurrence of Idiopathic Hypereosinophilic Syndrome in End-Stage Renal Disease Patients Undergoing Maintenance Hemodialysis.
Elbahoty, Mohamed; Elnaggar, Sherine; Soror, Nooran; Elkeraie, Ahmed; Youssef, Ayman.
Affiliation
  • Elbahoty M; Department of Pathology, University of Alabama at Birmingham, Birmingham, USA.
  • Elnaggar S; Department of Internal Medicine, Hematology Unit, Faculty of Medicine, Alexandria University, Alexandria, EGY.
  • Soror N; Nephrology and Hemodialysis Unit, Alexandria University Hospitals, Alexandria, EGY.
  • Elkeraie A; Department of Internal Medicine, Hematology Unit, Faculty of Medicine, Alexandria University, Alexandria, EGY.
  • Youssef A; Department of Internal Medicine, Nephrology and Hemodialysis Unit, Faculty of Medicine, Alexandria University, Alexandria, EGY.
Cureus ; 16(2): e53758, 2024 Feb.
Article in En | MEDLINE | ID: mdl-38465088
ABSTRACT
Hypereosinophilic syndrome (HES) is defined as the presence of (1) peripheral blood eosinophilia >1.5 x 109/L for at least one month, (2) evidence of eosinophil-mediated organ damage and/or dysfunction, and (3) exclusion of other potential causes of eosinophilia. In hemodialysis patients, HES has been associated with manifestations because of low blood pressure or gastrointestinal symptoms that result in dialysis intolerance. Very few cases of HES co-occurrence in dialysis patients have been reported in the literature, and their clinical characteristics are not fully understood. Here, we report two end-stage renal disease patients diagnosed with idiopathic HES while undergoing maintenance hemodialysis. The first patient presented with unexplained persistent pruritus and intradialytic hypotension, which started 10 minutes after the dialysis session initiation. Hematologic studies revealed hypereosinophilia which remarkably improved on steroid therapy. The second patient was accidentally discovered with asymptomatic persistent hypereosinophilia. His blood counts improved initially on interferon treatment before achieving full remission on steroid therapy. Neither of the two patients reported any history of allergy or atopic manifestations. Our case report sheds light on the possible occurrence of HES in hemodialysis patients which may be confused with other dialysis-related complications. Although steroids remain the mainstay of treatment, the optimal dose and duration of treatment remain unknown.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cureus Year: 2024 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cureus Year: 2024 Document type: Article Affiliation country: United States Country of publication: United States